It is a pharma private limited company based in Noida, Uttar Pradesh, India, established in 2012.
2012 | Noida, Uttar Pradesh, India | ActiveAnadi Pharma Private Limited, a active private limited company, was established on 12 December 2012 in Noida, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U52100UP2012PTC054088. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Jatashankar (Managing Director), Subhash Chandra Sahani (Director). Past directors included Abhishek Singh, Alka Singh, Pragya Singh. It holds ₹1.40 M open charges and no settled loans. Its latest AGM occurred on 30 December 2020, with the balance sheet filed on 31 March 2020. It is based at 4/166, 16Th Floor Palm Olympia, Gh 2 Sector 16C,Greater No, Ida (West), Noida, Uttar Pradesh, 201318.
U52100UP2012PTC054088
054088
12 December 2012
₹0.50 M
₹0.10 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Anadi Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jatashankar | Managing Director | 18 Apr 2024 | Current |
| Subhash Chandra Sahani | Director | 19 Apr 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 19 Apr 2024 | Past |
| Pramod Abcsdd | Director | 09 Aug 2019 | Past |
| Pramod Abcsdd | Director | 19 Apr 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Anadi Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 46.68% increase. The company also saw a substantial fall in profitability, with a 316.27% decrease in profit. The company's net worth observed a substantial decline by a decrease of 350.35%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Anadi Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,400,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Aug 2020 | Canara Bank | ₹0.20 M | Open |
| 04 Sep 2017 | Canara Bank | ₹1.20 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Anadi Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Anadi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anadi Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Jatashankar was appointed as a Managing Director was appointed as a Managing Director on 18 Apr 2024 & has been associated with this company since 1 year 7 months . was recorded as a recent event.
Progress on Subhash Chandra Sahani was appointed as a Director was appointed as a Director on 19 Apr 2021 & has been associated with this company since 4 years 7 months . was documented.
Progress on Anadi Pharma Private Limited last Annual general meeting of members was held on 30 Dec 2020 as per latest MCA records. was documented.
The activity A charge with Canara Bank of Rs. 1.20 M registered on 04 Sep 2017 with Charge ID 100175597 was modified on 18 Sep 2020. was completed.
The activity A charge with Canara Bank amounted to Rs. 0.20 M with Charge ID 100375509 was registered on 13 Aug 2020. was completed.
The activity Anadi Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Kanpur. was completed.
The CIN of Anadi Pharma Private Limited is U52100UP2012PTC054088.
Anadi Pharma Private Limited is headquartered at 4/166, 16Th Floor Palm Olympia, Gh 2 Sector 16C,Greater No, Ida (West), Noida, Uttar Pradesh, 201318.
Anadi Pharma Private Limited was incorporated on 12 December 2012.
The current directors of Anadi Pharma Private Limited are
The primary industry of Anadi Pharma Private Limited is Trade.
Anadi Pharma Private Limited is unlisted.
The authorized capital of Anadi Pharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Anadi Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX